摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(4-acetoxymethyl-2-methyl-4,5-dihydro-oxazol-4-yl)-methanol | 98426-85-8

中文名称
——
中文别名
——
英文名称
(4-acetoxymethyl-2-methyl-4,5-dihydro-oxazol-4-yl)-methanol
英文别名
[4-(hydroxymethyl)-2-methyl-5H-1,3-oxazol-4-yl]methyl acetate
(4-acetoxymethyl-2-methyl-4,5-dihydro-oxazol-4-yl)-methanol化学式
CAS
98426-85-8
化学式
C8H13NO4
mdl
——
分子量
187.196
InChiKey
ZQILTRXOJIHAFS-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.1
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.75
  • 拓扑面积:
    68.1
  • 氢给体数:
    1
  • 氢受体数:
    5

反应信息

点击查看最新优质反应信息

文献信息

  • SOLID PHASE CHANGE INK COMPOSITIONS COMPRISING OXAZOLINES
    申请人:Carlini Rina
    公开号:US20130032057A1
    公开(公告)日:2013-02-07
    A solid ink composition comprising at least one crystalline oxazoline compound and at least one amorphous component derived from a polyol, and a colorant and optional viscosity modifier, which are suitable for inkjet printing, including printing on coated paper substrates. In embodiments, the solid ink formulation comprises a blend of an amorphous and crystalline components which provides a solid ink with excellent robustness when forming images or printing on coated paper substrates.
    一种固体油墨组合物,包括至少一种结晶的噁唑啉化合物和至少一种来自多元醇的非晶组分,以及一种色料和可选的粘度调节剂,适用于喷墨打印,包括在涂层纸基底上打印。在实施例中,固体油墨配方包括非晶和结晶组分的混合物,提供具有卓越韧性的固体油墨,用于形成图像或在涂层纸基底上打印。
  • INK COMPOSITIONS INCORPORATING SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES
    申请人:CARLINI Rina
    公开号:US20120274710A1
    公开(公告)日:2012-11-01
    An ink composition including one or more oxazoline compounds or oxazoline derivatives having either crystalline, amorphous or even semi-crystalline properties for use in a particular printing application, such as in a direct-to-paper print process.
  • Phase Separation Ink
    申请人:Odell Peter G.
    公开号:US20120274713A1
    公开(公告)日:2012-11-01
    A phase separation ink including at least one crystallizable component that crystallizes as it cools from a first ink jetting temperature to a second lower temperature; at least one amorphous component comprising a material that remains amorphous at the second temperature; an optional colorant; wherein the at least one crystallizable component and the at least one amorphous component are in a molten, single phase state at the first ink jetting temperature; wherein at the second temperature, the phase separation ink comprises a crystalline phase comprising the at least one crystallizable component and an amorphous phase comprising the at least one amorphous component; wherein the amorphous phase of the at least one phase separation ink substantially penetrates into the final image receiving substrate and the crystalline phase of the at least one phase separation ink substantially remains on the surface of the final image receiving substrate.
  • SUBSTITUTED OXAZOLINE COMPOUNDS OR SUBSTITUTED OXAZOLINE DERIVATIVES
    申请人:CARLINI Rina
    公开号:US20120272859A1
    公开(公告)日:2012-11-01
    Substituted oxazoline compounds and/or substituted oxazoline derivatives having amorphous, semi-crystalline, or crystalline properties and methods for producing such compounds and derivatives are presented. The substituted oxazoline compounds and/or substituted oxazoline derivatives are useful for various applications. For example, the substituted oxazoline compounds and/or substituted oxazoline derivatives may function as phase-change agents, a binder resins, rheology modifiers or plasticizers for ink compositions.
  • Phase Change Inks Containing Oxazoline Compounds and Polyterpene Resins
    申请人:Carlini Rina
    公开号:US20130035428A1
    公开(公告)日:2013-02-07
    Disclosed is a phase change ink comprising (a) a crystalline oxazoline compound; and (b) an amorphous polyterpene resin.
查看更多

同类化合物

(甲基3-(二甲基氨基)-2-苯基-2H-azirene-2-羧酸乙酯) (±)-盐酸氯吡格雷 (±)-丙酰肉碱氯化物 (d(CH2)51,Tyr(Me)2,Arg8)-血管加压素 (S)-(+)-α-氨基-4-羧基-2-甲基苯乙酸 (S)-阿拉考特盐酸盐 (S)-赖诺普利-d5钠 (S)-2-氨基-5-氧代己酸,氢溴酸盐 (S)-2-[[[(1R,2R)-2-[[[3,5-双(叔丁基)-2-羟基苯基]亚甲基]氨基]环己基]硫脲基]-N-苄基-N,3,3-三甲基丁酰胺 (S)-2-[3-[(1R,2R)-2-(二丙基氨基)环己基]硫脲基]-N-异丙基-3,3-二甲基丁酰胺 (S)-1-(4-氨基氧基乙酰胺基苄基)乙二胺四乙酸 (S)-1-[N-[3-苯基-1-[(苯基甲氧基)羰基]丙基]-L-丙氨酰基]-L-脯氨酸 (R)-乙基N-甲酰基-N-(1-苯乙基)甘氨酸 (R)-丙酰肉碱-d3氯化物 (R)-4-N-Cbz-哌嗪-2-甲酸甲酯 (R)-3-氨基-2-苄基丙酸盐酸盐 (R)-3-BOC-5-甲基-1,2,3-氧杂噻唑烷-2,2-二氧化物 (R)-2-苯基-3-羟基丙酸 (R)-2-羟基-2-(2-(2-(2-甲氧基-5-甲基吡啶-3-基)乙基)-琥珀酸 (R)-1-(3-溴-2-甲基-1-氧丙基)-L-脯氨酸 (N-[(苄氧基)羰基]丙氨酰-N〜5〜-(diaminomethylidene)鸟氨酸) (6-氯-2-吲哚基甲基)乙酰氨基丙二酸二乙酯 (4S)-4-叔丁基-1,2,3-氧杂噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S)-4-i-丙基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4R)-N-亚硝基噻唑烷-4-羧酸 (4R)-4-叔丁基-1,2,3-氧杂噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (3R)-1-噻-4-氮杂螺[4.4]壬烷-3-羧酸 (3-硝基-1H-1,2,4-三唑-1-基)乙酸乙酯 (2S,4R)-Boc-4-环己基-吡咯烷-2-羧酸 (2S,3S,5S)-2-氨基-3-羟基-1,6-二苯己烷-5-N-氨基甲酰基-L-缬氨酸 (2S,3S)-3-((S)-1-((1-(4-氟苯基)-1H-1,2,3-三唑-4-基)-甲基氨基)-1-氧-3-(噻唑-4-基)丙-2-基氨基甲酰基)-环氧乙烷-2-羧酸 (2S,3R)-2,3-二羟基-3-(2-吡啶基)丙酸乙酯,N-氧化物 (2S)-2,6-二氨基-N-[4-(5-氟-1,3-苯并噻唑-2-基)-2-甲基苯基]己酰胺二盐酸盐 (2S)-2-氨基-N,3,3-三甲基-N-(苯甲基)丁酰胺 (2S)-2-氨基-3-甲基-N-2-吡啶基丁酰胺 (2S)-2-氨基-3,3-二甲基-N-(苯基甲基)丁酰胺, (2S)-2-氨基-3,3-二甲基-N-2-吡啶基丁酰胺 (2S,4R)-1-((S)-2-氨基-3,3-二甲基丁酰基)-4-羟基-N-(4-(4-甲基噻唑-5-基)苄基)吡咯烷-2-甲酰胺盐酸盐 (2R,3'S)苯那普利叔丁基酯d5 (2R)-2-氨基-3,3-二甲基-N-(苯甲基)丁酰胺 (2-氯丙烯基)草酰氯 (2-三甲基甲硅烷基)-乙氧基甲基三氟硼酸钾 (1S,3S,5S)-2-Boc-2-氮杂双环[3.1.0]己烷-3-羧酸 (1R,5R,6R)-5-(1-乙基丙氧基)-7-氧杂双环[4.1.0]庚-3-烯-3-羧酸乙基酯 (1R,4R,5S,6R)-4-氨基-2-氧杂双环[3.1.0]己烷-4,6-二羧酸 (11bR,11''bR)-2,2''-[氧双(亚甲基)]双[4-羟基-4,4''-二氧化物-二萘并[2,1-d:1'',2''-f][1,3,2]二氧磷杂七环 (11aR)-10,11,12,13-四氢-5-羟基-3,7-二-1-萘-5-氧化物-二茚基[7,1-de:1'',7''-fg][1,3,2]二氧杂磷杂八环 (1-氨基丁基)磷酸 (-)-N-[(2S,3R)-3-氨基-2-羟基-4-苯基丁酰基]-L-亮氨酸甲酯 齐特巴坦